TGF-β is a profibrogenic cytokine and the impairment in TGF-β signaling in COPD patients induces fibrotic airway remodeling that could promote a decline in lung function (Morty et al., 2009). The gene discussed is TGFB1; the disease is chronic obstructive pulmonary disease.